Medacta Group SA Stock price

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Delayed Swiss Exchange 04:26:27 2024-03-28 am EDT 5-day change 1st Jan Change
120.8 CHF 0.00% Intraday chart for Medacta Group SA -3.67% -3.82%

Financials

Sales 2024 * 597M 644M 584M Sales 2025 * 676M 730M 661M Capitalization 2.46B 2.65B 2.4B
Net income 2024 * 77M 83.09M 75.29M Net income 2025 * 88M 94.96M 86.04M EV / Sales 2024 * 4.36 x
Net Debt 2024 * 147M 159M 144M Net Debt 2025 * 125M 134M 122M EV / Sales 2025 * 3.82 x
P/E ratio 2024 *
32.1 x
P/E ratio 2025 *
27.4 x
Employees 1,696
Yield 2024 *
0.65%
Yield 2025 *
0.77%
Free-Float 30.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.33%
1 week-3.67%
Current month-4.58%
1 month-6.36%
3 months-5.03%
6 months+4.68%
Current year-3.82%
More quotes
1 week
120.00
Extreme 120
125.60
1 month
118.00
Extreme 118
132.00
Current year
118.00
Extreme 118
135.00
1 year
98.00
Extreme 98
135.00
3 years
76.70
Extreme 76.7
173.00
5 years
39.80
Extreme 39.8
173.00
10 years
39.80
Extreme 39.8
173.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 18-10-31
Director of Finance/CFO 56 07-12-31
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 20-12-17
Director/Board Member 67 18-12-31
Director/Board Member 59 18-12-31
More insiders
Date Price Change Volume
24-03-28 120.8 0.00% 1 138
24-03-27 120.8 +0.33% 9,806
24-03-26 120.4 -1.63% 9,308
24-03-25 122.4 -0.49% 11,415
24-03-22 123 -1.91% 8,600

Delayed Quote Swiss Exchange, March 28, 2024 at 04:26 am EDT

More quotes
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
123.3 EUR
Average target price
147.9 EUR
Spread / Average Target
+19.91%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Medacta Group SA - Swiss Exchange